Midterm Outcomes of Handmade Pericardial Valved Conduits in Congenital Heart Disease: A Viable Cost-Effective Alternative in Resource-Limited Settings
European Journal of Cardio-Thoracic Surgery · 2026
DOI: 10.1093/ejcts/ezag097 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2026. Verfasst von Naimisha Yenduri und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Cardiology, Amrita Institute of Medical Sciences, Kochi 682041, Kerala, India. Hauptthemen laut MEDLINE: Heart Defects, Congenital, Heart Valve Prosthesis, Pericardium, Heart Valve Prosthesis Implantation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Objectives
The availability and affordability of conduits have significantly challenged congenital heart surgery in low-resource settings. We present the intermediate-term outcomes of low-cost customized handmade conduits at our institution.
Methods
Analysis of our surgical database and hospital information system (2016-2023) was done. Handmade conduits (cost: 30% of commercial conduits) were prepared in the operating room prior to surgery, using bovine pericardium for the conduit body tailored to the exact required diameter, with 0.1 mm polytetrafluoroethylene (PTFE) valve leaflets.
Results
Handmade conduits were implanted in 185 patients [median age: 1.58 years (0.75-6.92), weight: 8.40 kg (6.30-17.03); conduit diameter 15 mm (13-20); cardiopulmonary bypass time 191.5 minutes (160-238) and cross-clamp time 106.5 minutes (73.8-145)]. Median ventilation duration was 19 hours (7-39), intensive care unit (ICU) stay 72 hours (44-120), and hospital stay 15 days (IQR: 11-20); mortality was 3.8%. The median follow-up duration was 29.5 months (14-59.5) for 160 patients. Peak conduit gradient on follow-up was 40 mm Hg (IQR: 22.8-63.8). Significant conduit regurgitation was noted in 21.2%. Endocarditis occurred in 7 (4.3%) patients (late in 4, early in 3). Re-interventions included 22 transcatheter procedures [18 balloon, 4 stents] at a median of 24 (12.2-34.7) months from conduit implantation. Of the 160 patients on follow-up, 28 had their conduits replaced at a median of 37 months (21-65 months) from implantation. Freedom from the composite end-point of reintervention/reoperation/death was 94% at 1 year; 70% at 5 years.
Conclusions
Handmade pericardial valved conduits are a potentially attractive low-cost alternative to commercially available conduits in low-resource settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Cardiology, Amrita Institute of Medical Sciences, Kochi 682041, Kerala, India.
- Cardiovascular and Thoracic Surgery, Amrita Institute of Medical Sciences, Kochi 682041, Kerala, India.
ORCID-Profile: Naimisha Yenduri, Praveen Reddy Bayya, Navaneetha Sasikumar, Balaji Srimurugan, Brijesh P Kottayil
Zitieren
APA
Yenduri, N., Bayya, P. R., Sasikumar, N., Srimurugan, B., Kottayil, B. P., & Kumar, R. K. (2026). Midterm Outcomes of Handmade Pericardial Valved Conduits in Congenital Heart Disease: A Viable Cost-Effective Alternative in Resource-Limited Settings. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezag097
Vancouver
Yenduri N, Bayya PR, Sasikumar N, Srimurugan B, Kottayil BP, Kumar RK. Midterm Outcomes of Handmade Pericardial Valved Conduits in Congenital Heart Disease: A Viable Cost-Effective Alternative in Resource-Limited Settings. European Journal of Cardio-Thoracic Surgery. 2026. doi:10.1093/ejcts/ezag097
BibTeX
@article{Yenduri2026,
author = {Yenduri, Naimisha and Bayya, Praveen Reddy and Sasikumar, Navaneetha and Srimurugan, Balaji and Kottayil, Brijesh P and Kumar, Raman Krishna},
title = {Midterm Outcomes of Handmade Pericardial Valved Conduits in Congenital Heart Disease: A Viable Cost-Effective Alternative in Resource-Limited Settings},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2026},
doi = {10.1093/ejcts/ezag097}
}
EUVIMED